title: Photodynamic therapy for choroidal neovascularization secondary to choroidal nevus.
abstract: OBJECTIVE
  To describe a patient treated with photodynamic therapy for subfoveal choroidal neovascularization secondary to choroidal nevus.
  
  
  METHODS
  Interventional case report.
  
  
  METHODS
  A 61-year-old woman presented with subfoveal choroidal neovascularization secondary to choroidal nevus and best-corrected visual acuity of 20/50. The choroidal neovascularization was treated with two verteporfin photodynamic therapy sessions, separated by 3 months.
  
  
  RESULTS
  The choroidal neovascularization was occluded after two sessions. Best-corrected visual acuity improved to 20/25 and remained stable throughout an 18-month follow-up.
  
  
  CONCLUSIONS
  Photodynamic therapy seems to be an effective treatment for subfoveal choroidal neovascularization secondary to choroidal nevus.
authors.affiliation: Department of Ophthalmology, Saint-Pierre University Hospital, Brussels, Belgium.
authors.forename: Dinu
authors.initials: D
authors.lastname: Stanescu
authors.forename: Sandrine
authors.initials: S
authors.lastname: Wattenberg
authors.forename: Salomon Y
authors.initials: SY
authors.lastname: Cohen
mesh_terms: D002830:Choroid Neoplasms / Q000150:complications*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D008875:Middle Aged; D009508:Nevus, Pigmented / Q000150:complications*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin